| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.09 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.05 | 0.09 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.065 | 0.09 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.065 | 0.09 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.087 | 0.09 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.09 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.09 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.09 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.083 | 0.09 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |